HPV Vaccine Impact: Cervical Cancer Prevention

Visualizing the global success and inequity of HPV vaccination programs in preventing cervical cancer (2006-2024).

87% reduction in cervical cancer rates in vaccinated cohorts, yet 90% of deaths occur in low/middle-income countries with limited vaccine access.

Visual Encoding

Circle Size / 3D Height:

Circle Color:

Global Impact

Countries with Programs 146

Avg Coverage (Global) 48%

High-Income Coverage 84%

Low-Income Coverage 27%

Potential Lives Saved/Year 311K

Vaccine Timeline

2006 First HPV vaccine approved (Gardasil)

2009 20 countries adopt national programs

2014 WHO recommends HPV vaccination

2019 100+ countries with programs

2024 146 countries, but coverage gaps persist

Legend

Color Scale: Cervical Cancer Incidence

Low (2 per 100K) High (44 per 100K)

Size/Height: HPV Vaccine Coverage

0% (No program) 95% (High coverage)

Gender Equity & Health Justice

Cervical cancer is almost entirely preventable through HPV vaccination, yet remains the 4th most common cancer in women globally.

Health Inequity: High-income countries achieve 80%+ coverage while low-income countries struggle below 30%, perpetuating preventable deaths among the world's most vulnerable women.

3D Visualization Mode: When 3D cancer burden is enabled, column heights represent annual cervical cancer deaths. Taller columns indicate higher death burden, visualizing the devastating impact in regions with low vaccine coverage.